CDK5 and Parkinson disease: Altering Cdk5 activity also hyperphosphorylates and inhibits peroxiredoxin 2 (Prx2), an antioxidant enzyme; elevated levels of phosphorylated Prx2 were found in brain tissue of PD patients (Qu et al., 2007).